Latest Breaking News On - Infectious diseases analytical research unit - Page 1 : comparemela.com

Green light for Covaxin likely in 4-6 weeks: WHO expert A WHO pre-qualification, or Emergency Use Listing, is necessary for a vaccine manufacturer to supply vaccines to global entities such as COVAX or even internationally. Share Via Email   |  A+A A- A health worker shows the vials fo Covaxin dose, at a vaccination centre in Kolkata. (Photo | PTI) Express News Service BENGALURU: The World Health Organisation (WHO) is likely to take a decision on including Bharat Biotech’s Covaxin in its list of vaccines approved for emergency use, in four to six weeks, the world body’s Chief Scientist Dr Soumya Swaminathan has said. A WHO pre-qualification, or Emergency Use Listing, is necessary for a vaccine manufacturer to supply vaccines to global entities such as COVAX or even internationally.

South africaShabira madhiSoumya swaminathanChetana belagereCentre for scienceInfectious diseases analytical research unitNews serviceUniversity of the witwatersrandWorld health organisationBharat biotechChief scientist dr soumya swaminathanEmergency use listingசௌமிய சுவாமிநாதன்மையம் க்கு அறிவியல்தொற்று நோய்கள் பகுப்பாய்வு ஆராய்ச்சி அலகுசெய்தி சேவை